“…Researchers have discovered disruptions of FCN in neuropsychiatric diseases, such as Alzheimer's disease (Greicius, Srivastava, Reiss, & Menon, ; Wang et al, ), mild cognitive impair (MCI) (Bai et al, ; Das et al, ), depression (Greicius et al, ; Yang et al, ), autism spectrum disorder (ASD) (Anderson et al, ; Assaf et al, ; Cheng, Rolls, Gu, Zhang, & Feng, ; Ebisch et al, ), and schizophrenia (Wang, Xia, et al, ). On the other hand, machine learning techniques have been proven to be very effective in identifying biomarkers for brain disease diagnosis based on FCN (Chen, Zhang, et al, ; Jiang, Zhang, & Zhu, ; Khazaee, Ebrahimzadeh & Babajani‐Feremi, ; Sato et al, ; Wee, Yap, Zhang, Wang, & Shen, ; Zhang, Hu, Ma, & Xu, ). Here, we focus on exploring biomarkers from FCN for ASD diagnosis using state‐of‐the‐art machine learning techniques.…”